Chairpersons : Kwan-Woo Lee (Ajou University, Korea), Sang Yong Kim (Chosun University, Korea)
|
07:30-07:45 |
Beyond the statin; Start early, switch now
Da Hea Seo (Inha University, Korea)
|
|
07:45-08:00 |
The necessity of SGLT2i in the management of CKM syndrome
Seung Jin Han (Ajou University, Korea)
|
Chairpersons : Kyu Jeung Ahn (Kyung Hee University, Korea), Bon Jeong Ku (Chungnam National University, Korea)
|
|
07:30-07:45 |
Managing residual atherogenic dyslipidemia in patients with type 2 diabetes
Ji Eun Lee (CHA University, Korea)
|
|
|
07:45-08:00 |
One pill, broader benefits: Esgliteo in the early T2D journey
Gyuri Kim (Sungkyunkwan University, Korea)
|
Chairpersons : Chang Beom Lee (Hanyang University, Korea), Heung Yong Jin (Jeonbuk National University, Korea)
|
07:30-07:45 |
Beyond LDL-C reduction comprehensive lipid control in DM patients
Jun Hwa Hong (Eulji University, Korea)
|
|
07:45-08:00 |
Clinical use of original denosumab: Who, when, and how long?
Hye-Sun Park (Yonsei University, Korea)
|
Chairpersons : Kwang-Won Kim (Gachon University, Korea), Seung-Hwan Lee (The Catholic University of Korea, Korea)
|
|
07:30-07:45 |
TBD
Jung Hwan Park (Hanyang University, Korea)
|
|
07:45-08:00 |
TZD+SGLT-2i combination therapy: Benefits for diabetic complications and MASLD
Yeoree Yang (The Catholic University of Korea, Korea)
|